Medical Specialty >> Pharmacy

Doctors Lounge - Pharmacy Answers

Back to Pharmacy Answers List

If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge ( does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site.

DISCLAIMER: The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.

Date of last update: 9/5/2017.

Forum Name: Pharmacy & Drug Topics

Question: Used a cream that's now being considered for black box label

 FearfuL - Wed Feb 23, 2005 12:08 am

There's been reports that Protopic is being considered for a black box label because of risk of skin cancer and lymphoma. There were some post marketing reports of "cancer related adverse affects". Now, I only used this ointment (around my lip) last week for a couple of days. Literally just a couple.

What are the chances that I'm affected by this? Slim to none?
 Dr. Anthony Solomon - Fri Mar 04, 2005 8:03 pm

Tacrolimus (marketed under the name of Protopic) is licensed for topical use in moderate to severe atopic eczema.

It is a new drug whose long-term safety and place in therapy is still being evaluated. It should therefore not be considered as first-line treatment unless there is a specific reason to avoid or reduce the use of topical steroids.

There is no reason to be worried if you used it for a few days.

Dr Anthony Solomon
Consultant Physician, Tropical & Genitourinary Medicine

| Check a doctor's response to similar questions

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us